Why the study?
How do serum levels of MMP-1, MMP-2, and MMP-9 change in response to myocardial infarction and percutaneous revascularization?
How do serum levels of MMP-1, MMP-2, and MMP-9 change in response to myocardial infarction and percutaneous revascularization?
Serial monitoring of matrix metalloproteinases reveals distinct subtype responses to myocardial infarction and percutaneous revascularization, suggesting differing roles in acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Distinct MMP-2/MMP-9 patterns may refine post-MI phenotyping; leaves open targeted interventions pending prospective validation.
Eckart et al. (2004) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: